Hypothesis-Agnostic Network-Based Analysis of Real-World Data Suggests Ondansetron is Associated with Lower COVID-19 Any Cause Mortality.
Gregory M MillerJ Austin EllisRangaprasad SarangarajanAmay ParikhLeonardo O RodriguesCan BruceNischal Mahaveer ChandSteven R SmithKris RichardsonRaymond VazquezMichael A KiebishChandran HaneeshElder GrangerJudy HoltzJacob HinkleNiven R NarainBret GoodpasterJeremy C SmithDaniel S LupuPublished in: Drugs - real world outcomes (2022)
The results demonstrate how a real-world COVID-19-focused data analysis using artificial intelligence can generate unexpected yet valid insights that could possibly support clinical decision making and minimize the future loss of lives and resources.